Analysts have recently evaluated SI-BONE and provided 12-month price targets. The average target is $18.0, accompanied by a ...

In this study, our results uncover the function and mechanism of CHMP5 in the regulation of cell senescence and bone formation in osteogenic cells. Deletion of Chmp5 causes endolysosomal dysfunction ...

It is common to hear patients comment about posture either because someone has made a comment about their posture, or they ...

SI-BONE (NASDAQ:SIBN – Free Report) had its target price upped by Truist Financial from $16.00 to $18.00 in a research report ...

The shoulder is an amazing structure. The arm’s upper bone, the humerus, is joined to the shoulder girdle, allowing a high ...

More than 200,000 Medicare patients with back pain underwent $2 billion worth of unnecessary surgeries, including spinal fusion and/or laminectomy or vertebroplasty, over a recent 3-year period, ...

SANTA CLARA, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving sacropelvic disorders, today reported financial results for the ...

The research, which involved bone density scans of over 1,000 children ... "Rickets is characterised by the softening and ...

A revolutionary Total Knee Replacement (TKR) was performed on a patient with severe osteoarthritis and significant deformities. The complex procedure utilized state-of-the-art robotic-assisted ...

BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to providing surgical solutions for sacropelvic disorders, today announced that the Centers for Medicare & Medicaid ...

Bone cancer is characterized by uncontrolled growth of cells of the bone. Primary bone cancer (that arises directly in the bone), is relatively rare. Different types of bone tissue give rise to ...